摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid | 14383-42-7

中文名称
——
中文别名
——
英文名称
1-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid
英文别名
1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid;1-Methyl-2,4-dioxo-1,2,3,4-tetrahydro-pyrimidin-5-carbonsaeure;1-Methyl-5-carboxyuracil;5-Carboxy-1-methyluracil;1-methyl-2,4-dioxopyrimidine-5-carboxylic acid
1-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid化学式
CAS
14383-42-7
化学式
C6H6N2O4
mdl
MFCD11099499
分子量
170.125
InChiKey
POFQIFXCMBGLKO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    266 °C (decomp)
  • 密度:
    1.545±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -0.5
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.166
  • 拓扑面积:
    86.7
  • 氢给体数:
    2
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2933599090

SDS

SDS:d986a6288b6ca08b1ec52a90e1646af4
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Atkinson et al., Journal of the Chemical Society, 1957, p. 2363,2365
    摘要:
    DOI:
  • 作为产物:
    描述:
    溶剂黄146 作用下, 反应 0.33h, 以246 mg的产率得到1-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid
    参考文献:
    名称:
    New Uracil Dimers Showing Erythroid Differentiation Inducing Activities
    摘要:
    The synthesis of C5 linked uracil dimers was carried out according to a model developed in order to bind adenine in DNA. NI-Alkylated uracil derivatives were synthesized from isoorotic acid (uracil-5-carboxylic acid) or thymine. The carboxylic acid derivatives were condensed with diamines in order to produce dimeric compounds or with monoamines in order to obtain reference monomeric compounds. Some of the derivatives, in particular the uracil dimers, showed antiproliferative and erythroid differentiation induction properties towards human chronic myelogenous leukemia K562 cells, thus indicating that these compounds could represent a new class of drugs useful for the development of antitumor therapy based on the ability to induce terminal differentiation.
    DOI:
    10.1021/jm800982q
点击查看最新优质反应信息

文献信息

  • [EN] COMPOUND HAVING AXL AND C-MET KINASE INHIBITORY ACTIVITY, PREPARATION THEREOF AND APPLICATION THEREOF<br/>[FR] COMPOSÉ AYANT UNE ACTIVITÉ INHIBITRICE DE LA KINASE AXL ET DE LA KINASE C-MET, SA PRÉPARATION ET SON APPLICATION<br/>[ZH] 具有Axl与c-Met激酶抑制活性的化合物及其制备和应用
    申请人:SHANGHAI INST MATERIA MEDICA CAS
    公开号:WO2021043217A1
    公开(公告)日:2021-03-11
    一种具有Axl与c-Met激酶抑制活性的化合物及其制备方法和应用。具体地,具有式(I)所示结构的化合物、其制备方法及其在制备治疗和/或预防肿瘤相关疾病和/或激酶相关疾病的药物中的应用。
  • METHODS OF PREPARING LIPID NANOPARTICLES
    申请人:Modernatx, Inc.
    公开号:EP3917503A1
    公开(公告)日:2021-12-08
  • JPS6110565A
    申请人:——
    公开号:JPS6110565A
    公开(公告)日:1986-01-18
  • SUBSTRATE REDUCTION THERAPY
    申请人:The Chancellor, Masters and Scholars of the University of Oxford
    公开号:US20140080769A1
    公开(公告)日:2014-03-20
    The present invention provides a compound which is an inhibitor of sphingolipid biosynthesis for use in the treatment of a disease which has a secondary Niemann-Pick type C disease like cellular phenotype.
  • US5721234A
    申请人:——
    公开号:US5721234A
    公开(公告)日:1998-02-24
查看更多